Effect of NADPH oxidase inhibitor apocynin on human lung cancer A549 cells via Bcl-2, Bax, caspase-3, and NF-κB signaling pathway
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-08 · 398 (8) · 10071-10082
DOI: 10.1007/s00210-025-03833-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 13.02.2025. Verfasst von Betul Apaydın Yıldırım und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Veterinary, Ataturk University, Erzurum, Türkiye. betulapaydin@atauni.edu.tr. Hauptthemen laut MEDLINE: Acetophenones, Lung Neoplasms, NADPH Oxidases, Enzyme Inhibitors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Atatürk University Scientific Research Projects Coordination Office, Erzurum, Turkey., Atatürk University Scientific Research Projects Coordination Office, Erzurum, Turkey., Ataturk University.
Abstract (Originalsprache)
Apocynin (AP) is an anti-inflammatory drug with different therapeutic effects. This study aimed to investigate the antiproliferative, apoptotic, and antioxidant effects of AP on human lung adenocarcinoma cells (A549) and to investigate the effects on Bax, Bcl-2, NF-κB, and caspase-3 signaling pathways that may play a role in the pathogenesis of lung cancer. Cell viability was measured by MTT and cell apoptosis, and detection of cell death was measured by ELISA. IMA, AOPP, MDA, and GSH levels, SOD and CAT activities, and Bcl-2, Bax, NF-κB, and caspase-3 expression levels were analyzed from the obtained cell lysates. As a result, according to the findings obtained, IMA and MDA levels decreased in the A549 cancer cell line, while GSH levels and SOD and CAT activity increased. It was determined that the application of apocynin to A549 cells significantly reduced cell viability and directed the cells to apoptosis, increased Bax, NF-κB, and caspase-3 expression, and decreased Bcl-2 expressions. Since all of the data obtained were not found in the literature about the use of apocynin in the A549, the study conducted is pioneering. Our study demonstrates the potential of apocynin for cancer therapy possibly targeting the apoptotic pathway. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Veterinary, Ataturk University, Erzurum, Türkiye. betulapaydin@atauni.edu.tr.
- Department of Biochemistry, Faculty of Veterinary, Ataturk University, Erzurum, Türkiye.
- Department of Pathology, Faculty of Veterinary, Ataturk University, Erzurum, Türkiye.
- Department of Internal Medicine, Faculty of Veterinary, Ataturk University, Erzurum, Türkiye.
- Department of Molecular Biology and Genetics, Faculty of Science, Ataturk University, Erzurum, Türkiye.
Förderung
- Atatürk University Scientific Research Projects Coordination Office, Erzurum, Turkey.
- Atatürk University Scientific Research Projects Coordination Office, Erzurum, Turkey.
- Ataturk University
Zitieren
APA
Yıldırım, B. A., Dogan, T., Bolat, İ., Ozcan, A. C., & Kocak, R. (2025). Effect of NADPH oxidase inhibitor apocynin on human lung cancer A549 cells via Bcl-2, Bax, caspase-3, and NF-κB signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(8), 10071-10082. https://doi.org/10.1007/s00210-025-03833-5
Vancouver
Yıldırım BA, Dogan T, Bolat İ, Ozcan AC, Kocak R. Effect of NADPH oxidase inhibitor apocynin on human lung cancer A549 cells via Bcl-2, Bax, caspase-3, and NF-κB signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(8):10071-10082. doi:10.1007/s00210-025-03833-5
BibTeX
@article{Yldrm2025,
author = {Yıldırım, Betul Apaydın and Dogan, Tuba and Bolat, İsmail and Ozcan, Ali Can and Kocak, Rabia},
title = {Effect of NADPH oxidase inhibitor apocynin on human lung cancer A549 cells via Bcl-2, Bax, caspase-3, and NF-κB signaling pathway},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
volume = {398},
number = {8},
pages = {10071--10082},
doi = {10.1007/s00210-025-03833-5}
}
EUVIMED